Reports Q2 revenue $11M, vs. $8.26M last year. “We are pleased with both our second quarter performance, which was in-line with the preliminary estimates, and the momentum in our business,” said Rob Ball, CEO of Shoulder Innovations (SI). “Our financial results and operational progress reflect accelerating market adoption of our advanced implant systems for anatomic and reverse total shoulder arthroplasty. Additionally, we are expanding our base of surgeon customers, which increased nearly 50% year-over-year in the second quarter.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SI:
- 2 New IPOs on the Street – Morgan Stanley Chooses the Superior Stock to Buy
- Figma initiated, Okta upgraded: Wall Street’s top analyst calls
- Shoulder Innovations initiated with an Overweight at Morgan Stanley
- Shoulder Innovations initiated with a Buy at Jefferies
- Shoulder Innovations initiated with an Overweight at Piper Sandler